GB9721692D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9721692D0
GB9721692D0 GBGB9721692.3A GB9721692A GB9721692D0 GB 9721692 D0 GB9721692 D0 GB 9721692D0 GB 9721692 A GB9721692 A GB 9721692A GB 9721692 D0 GB9721692 D0 GB 9721692D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9721692.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9721692.3A priority Critical patent/GB9721692D0/en
Publication of GB9721692D0 publication Critical patent/GB9721692D0/en
Priority to APAP/P/2000/001788A priority patent/AP1223A/en
Priority to KR1020007003935A priority patent/KR20010024482A/ko
Priority to IL13551598A priority patent/IL135515A0/xx
Priority to JP2000515579A priority patent/JP2001519383A/ja
Priority to PCT/GB1998/003067 priority patent/WO1999018944A1/fr
Priority to PL98339804A priority patent/PL339804A1/xx
Priority to AU95471/98A priority patent/AU9547198A/en
Priority to BR9815220-3A priority patent/BR9815220A/pt
Priority to HU0003673A priority patent/HUP0003673A3/hu
Priority to SK532-2000A priority patent/SK5322000A3/sk
Priority to YU28700A priority patent/YU28700A/sh
Priority to UA2000042049A priority patent/UA66809C2/uk
Priority to EP98949088A priority patent/EP1023057A1/fr
Priority to CA002305289A priority patent/CA2305289A1/fr
Priority to CN98812016A priority patent/CN1281358A/zh
Priority to CZ20001298A priority patent/CZ20001298A3/cs
Priority to TR2000/00957T priority patent/TR200000957T2/xx
Priority to IDW20000670A priority patent/ID24439A/id
Priority to EA200000418A priority patent/EA200000418A1/ru
Priority to OA1200000107A priority patent/OA11519A/en
Priority to NO20001897A priority patent/NO20001897L/no
Priority to HR20000256A priority patent/HRP20000256A2/hr
Priority to BG104405A priority patent/BG104405A/xx
Priority to US09/949,585 priority patent/US20020006939A1/en
Priority to US10/154,725 priority patent/US20020137773A1/en
Priority to US10/822,978 priority patent/US20040192737A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9721692.3A 1997-10-13 1997-10-13 Novel treatment Ceased GB9721692D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment
OA1200000107A OA11519A (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia.
UA2000042049A UA66809C2 (uk) 1997-10-13 1998-10-12 Спосіб лікування гіперглікемії похідною тіазолідиндіону
CA002305289A CA2305289A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie
IL13551598A IL135515A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
JP2000515579A JP2001519383A (ja) 1997-10-13 1998-10-12 高血糖症治療のためのチアゾリジンジオンの使用
PCT/GB1998/003067 WO1999018944A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie
PL98339804A PL339804A1 (en) 1997-10-13 1998-10-12 Application of thiazolydine diones in treating hyperglycaemia
AU95471/98A AU9547198A (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
BR9815220-3A BR9815220A (pt) 1997-10-13 1998-10-12 Uso de tiazolidinedionas para o tratamento da hiperglicemia
HU0003673A HUP0003673A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
SK532-2000A SK5322000A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia
YU28700A YU28700A (sh) 1997-10-13 1998-10-12 Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
APAP/P/2000/001788A AP1223A (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia.
EP98949088A EP1023057A1 (fr) 1997-10-13 1998-10-12 Utilisation de thiazolidinediones pour le traitement de l'hyperglycemie
KR1020007003935A KR20010024482A (ko) 1997-10-13 1998-10-12 고혈당증 치료용 티아졸리딘디온의 용도
CN98812016A CN1281358A (zh) 1997-10-13 1998-10-12 噻唑烷二酮在高血糖症治疗中的应用
CZ20001298A CZ20001298A3 (cs) 1997-10-13 1998-10-12 Léčivo pro léčení hyperglykémie a farmaceutický prostředek s obsahem sensitizéru inzulinu
TR2000/00957T TR200000957T2 (tr) 1997-10-13 1998-10-12 Hiperglisemi tedavisinde tiazolidinedion kullanımı
IDW20000670A ID24439A (id) 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia
EA200000418A EA200000418A1 (ru) 1997-10-13 1998-10-12 Применение тиазолидиндионов для лечения гипергликемии
NO20001897A NO20001897L (no) 1997-10-13 2000-04-12 Anvendelse av tiazolidindioner for behandling av hyperglycaemi
HR20000256A HRP20000256A2 (en) 1997-10-13 2000-05-02 Use of thiazolidinediones for the treatment of hyperglycaemia
BG104405A BG104405A (en) 1997-10-13 2000-05-05 The application of thiazolidindions for the treatment of hyperglycaemia
US09/949,585 US20020006939A1 (en) 1997-10-13 2001-09-10 Use of thiazolidinediones for the treatment of hyperglycaemia
US10/154,725 US20020137773A1 (en) 1997-10-13 2002-05-24 Use of thiazolidinediones for the treatment of hyperglycaemia
US10/822,978 US20040192737A1 (en) 1997-10-13 2004-04-13 Use of thiazolidinediones for the treatment of hyperglycaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
GB9721692D0 true GB9721692D0 (en) 1997-12-10

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9721692.3A Ceased GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Country Status (24)

Country Link
EP (1) EP1023057A1 (fr)
JP (1) JP2001519383A (fr)
KR (1) KR20010024482A (fr)
CN (1) CN1281358A (fr)
AP (1) AP1223A (fr)
AU (1) AU9547198A (fr)
BG (1) BG104405A (fr)
BR (1) BR9815220A (fr)
CA (1) CA2305289A1 (fr)
CZ (1) CZ20001298A3 (fr)
EA (1) EA200000418A1 (fr)
GB (1) GB9721692D0 (fr)
HR (1) HRP20000256A2 (fr)
HU (1) HUP0003673A3 (fr)
ID (1) ID24439A (fr)
IL (1) IL135515A0 (fr)
NO (1) NO20001897L (fr)
OA (1) OA11519A (fr)
PL (1) PL339804A1 (fr)
SK (1) SK5322000A3 (fr)
TR (1) TR200000957T2 (fr)
UA (1) UA66809C2 (fr)
WO (1) WO1999018944A1 (fr)
YU (1) YU28700A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002036A0 (en) * 1998-07-21 2001-03-31 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
CN1281358A (zh) 2001-01-24
YU28700A (sh) 2003-10-31
CZ20001298A3 (cs) 2001-08-15
IL135515A0 (en) 2001-05-20
SK5322000A3 (en) 2000-09-12
AP2000001788A0 (en) 2000-06-30
HRP20000256A2 (en) 2000-12-31
TR200000957T2 (tr) 2000-08-21
PL339804A1 (en) 2001-01-02
EA200000418A1 (ru) 2000-10-30
AU9547198A (en) 1999-05-03
NO20001897L (no) 2000-06-09
KR20010024482A (ko) 2001-03-26
WO1999018944A1 (fr) 1999-04-22
HUP0003673A3 (en) 2001-12-28
AP1223A (en) 2003-11-13
ID24439A (id) 2000-07-20
BG104405A (en) 2000-12-29
HUP0003673A2 (hu) 2001-10-28
NO20001897D0 (no) 2000-04-12
CA2305289A1 (fr) 1999-04-22
UA66809C2 (uk) 2004-06-15
JP2001519383A (ja) 2001-10-23
BR9815220A (pt) 2000-11-14
EP1023057A1 (fr) 2000-08-02
OA11519A (en) 2004-02-09

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
IL135343A0 (en) Novel aryloxy-alkyl-dialkylamines
GB9700899D0 (en) Novel treatment
GB9700939D0 (en) Therapy
GB9619492D0 (en) Novel treatment
GB9410512D0 (en) Novel treatment
GB9615767D0 (en) Novel treatment
GB9411635D0 (en) Novel treatment
GB9608657D0 (en) Novel treatment
TW366805U (en) Massager
GB9625795D0 (en) Novel treatment
GB9721692D0 (en) Novel treatment
GB2331514B (en) Effluent treatment
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
GB9612752D0 (en) Novel treatment
GB9721693D0 (en) Novel treatment
GB9716742D0 (en) Treatment
GB9828550D0 (en) Treatment
GB9616407D0 (en) Novel treatment
GB9604046D0 (en) Novel treatment
GB9625201D0 (en) Novel treatment
GB9616415D0 (en) Novel treatment
GB9614751D0 (en) Novel treatment
GB9616408D0 (en) Novel treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)